Hendershot Investments’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.79M | Hold |
7,128
| – | – | 0.23% | 44 |
|
|
2026
Q1 | $1.55M | Sell |
7,128
-550
| -7% | -$122K | 0.21% | 48 |
|
|
2025
Q4 | $1.75M | Sell |
7,678
-21
| -0.3% | -$4.78K | 0.22% | 47 |
|
|
2025
Q3 | $1.78M | Hold |
7,699
| – | – | 0.22% | 50 |
|
|
2025
Q2 | $1.43M | Hold |
7,699
| – | – | 0.19% | 51 |
|
|
2025
Q1 | $1.61M | Buy |
7,699
+28
| +0.4% | +$5.44K | 0.22% | 51 |
|
|
2024
Q4 | $1.36M | Buy |
7,671
+19
| +0.2% | +$3.49K | 0.19% | 53 |
|
|
2024
Q3 | $1.51M | Hold |
7,652
| – | – | 0.21% | 54 |
|
|
2024
Q2 | $1.31M | Hold |
7,652
| – | – | 0.19% | 56 |
|
|
2024
Q1 | $1.39M | Sell |
7,652
-300
| -4% | -$51.7K | 0.2% | 54 |
|
|
2023
Q4 | $1.23M | Hold |
7,952
| – | – | 0.19% | 57 |
|
|
2023
Q3 | $1.19M | Sell |
7,952
-558
| -7% | -$81.9K | 0.2% | 57 |
|
|
2023
Q2 | $1.15M | Hold |
8,510
| – | – | 0.19% | 58 |
|
|
2023
Q1 | $1.36M | Sell |
8,510
-1,040
| -11% | -$159K | 0.23% | 54 |
|
|
2022
Q4 | $1.54M | Buy |
9,550
+28
| +0.3% | +$4.29K | 0.26% | 58 |
|
|
2022
Q3 | $1.28M | Sell |
9,522
-8,825
| -48% | -$1.27M | 0.24% | 63 |
|
|
2022
Q2 | $2.81M | Sell |
18,347
-85
| -0.5% | -$13K | 0.5% | 46 |
|
|
2022
Q1 | $2.99M | Hold |
18,432
| – | – | 0.46% | 49 |
|
|
2021
Q4 | $2.5M | Buy |
+18,432
| New | +$2.18M | 0.38% | 57 |
|
|
2019
Q3 | – | Sell |
-157,156
| Closed | -$11.4M | – | 84 |
|
|
2019
Q2 | $11.4M | Sell |
157,156
-500
| -0.3% | -$39.3K | 3.75% | 4 |
|
|
2019
Q1 | $12.7M | Buy |
157,656
+3,620
| +2% | +$296K | 4.35% | 2 |
|
|
2018
Q4 | $14.2M | Buy |
154,036
+3,367
| +2% | +$296K | 5.6% | 2 |
|
|
2018
Q3 | $14.3M | Buy |
150,669
+4,057
| +3% | +$385K | 5.05% | 2 |
|
|
2018
Q2 | $13.6M | Buy |
146,612
+2,195
| +2% | +$214K | 5.22% | 3 |
|
|
2018
Q1 | $13.7M | Sell |
144,417
-2,810
| -2% | -$309K | 5.54% | 3 |
|
|
2017
Q4 | $14.2M | Sell |
147,227
-1,575
| -1% | -$148K | 5.73% | 3 |
|
|
2017
Q3 | $13.2M | Buy |
148,802
+1,429
| +1% | +$109K | 5.63% | 3 |
|
|
2017
Q2 | $10.7M | Buy |
147,373
+1,625
| +1% | +$109K | 4.8% | 3 |
|
|
2017
Q1 | $9.5M | Sell |
145,748
-1,008
| -0.7% | -$63.4K | 4.41% | 3 |
|
|
2016
Q4 | $9.19M | Buy |
146,756
+1,375
| +0.9% | +$83.9K | 4.41% | 3 |
|
|
2016
Q3 | $9.17M | Sell |
145,381
-842
| -0.6% | -$54.5K | 4.54% | 3 |
|
|
2016
Q2 | $9.05M | Buy |
146,223
+580
| +0.4% | +$35.3K | 4.65% | 2 |
|
|
2016
Q1 | $8.32M | Buy |
145,643
+7,355
| +5% | +$410K | 4.19% | 4 |
|
|
2015
Q4 | $8.19M | Buy |
138,288
+16,520
| +14% | +$952K | 4.38% | 3 |
|
|
2015
Q3 | $6.63M | Buy |
121,768
+5,512
| +5% | +$359K | 3.68% | 5 |
|
|
2015
Q2 | $7.81M | Buy |
116,256
+4,050
| +4% | +$264K | 4.09% | 4 |
|
|
2015
Q1 | $6.57M | Buy |
112,206
+7,545
| +7% | +$456K | 3.46% | 6 |
|
|
2014
Q4 | $6.85M | Buy |
104,661
+390
| +0.4% | +$24.6K | 3.59% | 5 |
|
|
2014
Q3 | $6.02M | Buy |
104,271
+10,595
| +11% | +$588K | 3.39% | 7 |
|
|
2014
Q2 | $5.29M | Sell |
93,676
-770
| -0.8% | -$40.4K | 3.11% | 10 |
|
|
2014
Q1 | $4.86M | Sell |
94,446
-737
| -0.8% | -$37.2K | 2.99% | 10 |
|
|
2013
Q4 | $5.03M | Sell |
95,183
-685
| -0.7% | -$33.7K | 3.26% | 8 |
|
|
2013
Q3 | $4.29M | Buy |
95,868
+745
| +0.8% | +$33K | 3.01% | 8 |
|
|
2013
Q2 | $3.93M | Buy |
+95,123
| New | +$4.16M | 2.98% | 13 |
|
Other funds holding ABBV
Hendershot Investments's ABBV Position: Q2 2026 in Review
Hendershot Investments held its AbbVie (ABBV) position steady in Q2 2026 at 7,128 shares worth $1.79M. The position accounts for 0.23% of the portfolio, ranked #44.
Hendershot Investments first reported a position in ABBV in Q2 2013 and has held it in 44 quarters since. The position peaked at $14.3M in Q3 2018. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Hendershot Investments held 7,128 shares of AbbVie worth $1.79M as of Q2 2026.
- Hendershot Investments left its AbbVie share count unchanged in Q2 2026.
- AbbVie made up 0.23% of Hendershot Investments's portfolio in Q2 2026, its #44 holding.
- Hendershot Investments first reported a position in AbbVie in Q2 2013 and has held it in 44 quarters since.
- Hendershot Investments's AbbVie position peaked at $14.3M in Q3 2018.
- 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Hendershot Investments's 13F filing for Q2 2026, filed 12 Aug 2026.